CClinicalTrials.gg
Not yet recruitingNCT07808632Updated Sep 9, 2026

Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography

An interventional study of Stress Ball in Femoral Arterial Sheath Removal, Stress Ball and Pain, sponsored by Mersin University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Mersin University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effects of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters. A total of 34 patients will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. Participants in the intervention group will use a stress ball during femoral arterial sheath removal in addition to routine care, while participants in the control group will receive routine care only. Pain, anxiety, patient satisfaction, and hemodynamic parameters will be assessed before and at specified time points after femoral arterial sheath removal.

Read the detailed description

Coronary angiography is a commonly used invasive procedure for the diagnosis and treatment of coronary artery disease. Following coronary angiography performed via the femoral artery, removal of the femoral arterial sheath may cause pain and anxiety and may lead to changes in hemodynamic parameters. Therefore, simple, safe, and nonpharmacological nursing interventions that can improve patient comfort during femoral arterial sheath removal are important.

This prospective, two-arm, randomized controlled trial aims to evaluate the effects of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters. The study will include 34 patients who meet the eligibility criteria. Participants will be randomly assigned in a 1:1 ratio to either the stress ball intervention group (n=17) or the control group (n=17) using block randomization.

Participants assigned to the intervention group will receive a stress ball immediately before femoral arterial sheath removal. A round, medium-firm silicone stress ball approximately 6 cm in diameter will be used. Participants will be instructed to hold the stress ball in their hand and rhythmically squeeze and release it after counting to three. The intervention will begin approximately one minute before femoral arterial sheath removal and will continue during and after sheath removal for a total of 10 minutes. Participants in the control group will receive routine clinical care without any additional nonpharmacological intervention.

Pain intensity will be assessed using the Visual Analog Scale (VAS), anxiety using the Visual Analog Scale for Anxiety (VAS-A), and patient satisfaction using the Visual Analog Scale for Patient Satisfaction (VAS-PS). Hemodynamic parameters will include systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation (SpO2).

Assessments will be performed at five predefined time points: immediately before femoral arterial sheath removal (T0), immediately after sheath removal (T1), and at 5 minutes (T2), 15 minutes (T3), and 30 minutes (T4) after the procedure. Routine medical treatment and nursing care will be continued for participants in both groups throughout the study.

The primary outcome of the study is pain intensity associated with femoral arterial sheath removal. Secondary outcomes include anxiety, patient satisfaction, systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation. The findings are expected to provide evidence regarding the effectiveness of stress ball use as a simple, low-cost, noninvasive nursing intervention during femoral arterial sheath removal after coronary angiography.

02

Conditions studied

  • Femoral Arterial Sheath Removal
  • Stress Ball
  • Pain
  • Anxiety
  • Patient Satisfaction
  • Hemodynamic Parameters
  • Nonpharmacological Intervention

Keywords

  • Femoral Arterial Sheath Removal
  • Stress Ball
  • Pain
  • Anxiety
  • Patient Satisfaction
  • Hemodynamic Parameters
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who underwent coronary angiography via the femoral artery and received stent implantation or balloon angioplasty
  • Aged 18 years or older
  • Willing to participate in the study and providing written informed consent
  • Conscious, oriented, and cooperative
  • Able to read and understand Turkish
  • No hearing or visual impairment that would interfere with participation
  • Clinically and hemodynamically stable
  • No diagnosed psychiatric disorder

Exclusion criteria

Exclusion Criteria:

  • Coronary angiography performed via the radial artery
  • Development of a complication during coronary angiography, such as arrhythmia
  • Administration of sedation during coronary angiography
  • Pregnancy
  • Prisoners or other vulnerable individuals
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Stress Ball Group

    Participants in this group will use a stress ball in addition to routine care. The stress ball intervention will begin approximately one minute before femoral arterial sheath removal and will continue during and after sheath removal for a total of 10 minutes.

    Behavioral: Stress Ball

  • No intervention
    Control Group

    Participants in this group will receive routine care only, without any additional nonpharmacological intervention.

Interventions

  • BehavioralStress Ball

    Participants will be given a round, medium-firm silicone stress ball approximately 6 cm in diameter. They will be instructed to hold the stress ball in the palm of their hand and rhythmically squeeze and release it after counting to three. The intervention will begin approximately one minute before femoral arterial sheath removal and will continue during and after sheath removal for a total of 10 minutes. Routine clinical care will continue throughout the intervention.

05

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst possible pain). Higher scores indicate greater pain intensity.

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

Secondary outcomes

  1. Anxiety Level

    Anxiety will be assessed using the Visual Analog Scale for Anxiety (VAS-A), a 10-cm scale ranging from 0 (no anxiety) to 10 (highest possible anxiety). Higher scores indicate greater anxiety.

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  2. Patient Satisfaction

    Patient satisfaction will be assessed using the Visual Analog Scale for Patient Satisfaction (VAS-PS), a 10-cm scale ranging from 0 (not satisfied at all) to 10 (completely satisfied). Higher scores indicate greater patient satisfaction.

    Time frame: Immediately before femoral arterial sheath removal and 30 minutes after removal.

  3. Systolic Blood Pressure

    Systolic blood pressure will be measured using a bedside patient monitor and recorded in millimeters of mercury (mmHg).

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  4. Diastolic Blood Pressure

    Diastolic blood pressure will be measured using a bedside patient monitor and recorded in millimeters of mercury (mmHg).

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  5. Heart Rate

    Heart rate will be measured using a bedside patient monitor and recorded as beats per minute (beats/min).

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  6. Respiratory Rate

    Respiratory rate will be assessed by counting the participant's respirations for one minute and recorded as breaths per minute.

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

  7. Peripheral Oxygen Saturation

    Peripheral oxygen saturation (SpO2) will be measured using a pulse oximeter and recorded as a percentage (%).

    Time frame: Immediately before femoral arterial sheath removal, immediately after removal, and 5, 15, and 30 minutes after removal.

06

Study locations

1 site
  • Turkey, Mersin University Hospital
    Yenişehir, Mersin 33120, Turkey (Türkiye)
07

References and documents

Publications

  • Akcoban S, Tosun B, Yuksel H. The Effect of Stress Ball Use on Immobilization Comfort, Pain Level, and Vital Signs in Patients After Coronary Angiography. J Cardiovasc Nurs. 2026 Jan-Feb 01;41(1):E25-E32. doi: 10.1097/JCN.0000000000001202. Epub 2025 Apr 9. PubMed 40198758 ↗
  • Yuksel D, Gunes D. The Effect of Stress Ball on Anxiety and Pain Levels in Angiography: A Randomized Controlled Trial. Cardiovasc Ther. 2024 Aug 24;2024:5049092. doi: 10.1155/2024/5049092. eCollection 2024. PubMed 39742013 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to participant confidentiality and data protection considerations. Aggregate study findings will be reported in scientific publications.

08

Registry details

Key details

Study ID
NCT07808632
Lead sponsor
Mersin University
Responsible party
Tugba CAM YANIK (Assistant Professor of Surgical Diseases Nursing, Mersin University) — Principal investigator
First posted
Sep 9, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Tuğba ÇAM YANIK, PHD
Contact
tugbacam@mersin.edu.tr
05067703216
TUGBA ÇAM YANIK, PHD, RN
Contact
tugbacam@mersin.edu.tr
Tuğba ÇAM YANIK
principal investigator · Mersin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion